Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Operating Margin (2020 - 2025)

Historic Operating Margin for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 40.14%.

  • RxSight's Operating Margin fell 140100.0% to 40.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.01%, marking a year-over-year decrease of 15500.0%. This contributed to the annual value of 26.34% for FY2024, which is 298900.0% up from last year.
  • RxSight's Operating Margin amounted to 40.14% in Q3 2025, which was down 140100.0% from 41.63% recorded in Q2 2025.
  • In the past 5 years, RxSight's Operating Margin registered a high of 21.46% during Q4 2024, and its lowest value of 319.6% during Q1 2021.
  • Over the past 5 years, RxSight's median Operating Margin value was 65.47% (recorded in 2023), while the average stood at 105.26%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by -2621600bps in 2021, then skyrocketed by 1443600bps in 2022.
  • RxSight's Operating Margin (Quarter) stood at 174.02% in 2021, then skyrocketed by 46bps to 93.18% in 2022, then skyrocketed by 59bps to 37.97% in 2023, then soared by 43bps to 21.46% in 2024, then crashed by -87bps to 40.14% in 2025.
  • Its Operating Margin stands at 40.14% for Q3 2025, versus 41.63% for Q2 2025 and 28.17% for Q1 2025.